Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Canadian Hearing Services launches Auracast™ for accessible business and public services across Canada
-
Thrive Appoints Kirti Gavri as SVP, Head of Corporate Development
-
Skyward Specialty Launches New Industry-First Well Decommissioning Solution
-
Xtreme Fighting Championships Returns To Argentina With XFC Young Guns Series
-
Vow ASA: Vow to deliver large pyrolysis reactor to Vow Green Metal at Follum in Q4 2025
-
Creighton University and Aon COO Mindy Simon Discuss the Effective and Ethical Application of AI in Business
-
Myseum, Inc. Partners with Creative Agency Spitball for Branding and Advertising of the New “Picture Party by Myseum” Social Sharing Platform
-
Maxion Therapeutics Appoints Joel Edwards as Chief Business Officer
-
PRIO Luxembourg Holding S.à r.l. announces cash tender offer for any and all of its outstanding 6.125% Senior Secured Notes due 2026
-
Dekuma to Present Next-Generation Rubber & Plastics Machines at K 2025
-
Dekuma to Present Next-Generation Rubber & Plastics Machines at K 2025
-
PRIO Luxembourg Holding S.à r.l. announces cash tender offer for any and all of its outstanding 6.125% Senior Secured Notes due 2026
-
ROCKWOOL A/S – transactions in connection with share buy-back programme
-
1911 Gold to Present at the Metals & Mining Virtual Investor Conference October 7, 2025
-
Primary.Health Launches Nation's First Advanced Newborn Screening Case Management Platform
-
1911 Gold to Present at the Metals & Mining Virtual Investor Conference October 7, 2025
-
HauntWorld Magazine Unveils Its 2025 List of the 13 Scariest Haunted Houses in the Country
-
Allied Universal Security Professional Nate Meininger Honored for Heroism at World’s Largest Security Industry Event
-
Primary.Health Launches Nation's First Advanced Newborn Screening Case Management Platform
-
Inuvo Appoints Rob Buchner as Chief Operating Officer to Accelerate Growth of IntentKey
-
Myrtelle Announces Nature Medicine Publication of Interim Results from Its Phase 1/2 Clinical Trial of Investigational Gene Therapy rAAV-Olig001-ASPA for Canavan Disease
-
MorningAI Unveils Autonomous Growth Platform for Brands
-
VCI Global Powers Food Security Technology Company Agroz (AGRZ) to Nasdaq: Successful IPO Pricing and Trading Begins Today
-
Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $205 Million Series A Financing
-
Catalyst Pharmaceuticals Announces $200 Million Share Repurchase Program
-
Parex Resources Announces Production Update and Timing of Q3 2025 Results
-
Volaris Group Acquires AskCody, Expanding Portfolio in Workplace and Meeting Management Solutions
-
CIRA introduces Cyber Stack: a Canadian cybersecurity suite to protect organizations against cyber threats
-
Canadian businesses risk falling behind without commitment to disability inclusion
-
Diabetes Canada launches “Type Resilient,” a new brand campaign recognizing the resilience of people living with diabetes
-
COUR Pharma Secures FDA Orphan Drug Designation for CNP-106 in Generalized Myasthenia Gravis
-
Global Uranium Corp. Announces Plans for Fieldwork in Wyoming, USA
-
CoreCivic Announces New Contract Award At Diamondback Correctional Facility
-
ORYZON Strengthens Patent Portfolio for iadademstat with European Grant Decision Covering Combinations with PD1/PD-L1 Inhibitors
-
ATMA CENA Grows National Mental Health Network to 13 Clinics
-
Magic Window App Pre-Orders Begin: Tool Helps Homeowners Fortify Against Extreme Weather
-
Fortress Biotech and Cyprium Therapeutics Announce an Update on the NDA for CUTX-101
-
Aeries Technology Delivers ~30% Faster Development Cycles Through AI-Enabled Engineering
-
Shoppers Plan to Spend More in 2026, but Loyalty Is Up for Grabs
-
Exceeding Beyond Expectations: Unlock Your Way with VOOPOO DRAG S3 & DRAG X3
-
Wisconsin Biotech Company Secures NIH Grant to Revolutionize Diabetes Treatment
-
NOVAGOLD Files Third Quarter 2025 Report
-
CRISPR Therapeutics to Present Preclinical Data on Alpha-1 Antitrypsin Deficiency (AATD) Utilizing Novel SyNTase Gene Editing Technology at the European Society of Gene and Cell Therapy (ESGCT) 2025 A
-
AEON Biopharma Announces FDA BPD Type 2a Meeting for ABP-450 on November 19
-
Asia Broadband Finalizes Milestone Production Agreement For Second Large-Scale Gold and Silver Ore Stockpile in Mexico
-
Zensurance: Cybercrime Affects More Than 50% of Small Businesses in Canada
-
CorVista Health Appoints Guido Neels and Dino Trevisani to Board of Directors
-
Sophos Launches Advisory Services to Deliver Proactive Cybersecurity Resilience
-
Radiopharm Theranostics Receives Positive Recommendation from Data Safety and Monitoring Committee (DSMC) to Accelerate 177Lu-RAD202 Phase 1 ‘HEAT’ Dose Escalation Clinical Trial
-
Integral Metals Corp. Provides Comprehensive Analysis of Soil Geochemical Survey at the KAP Project
